Ocera Therapeutics Inc

Available to platforms

Ocera Therapeutics Inc. (Ticker: OCRX) was a biopharmaceutical company focused on developing therapies for liver diseases. Its lead product candidate, OCR-002, was an ammonia-scavenging drug designed to treat hepatic encephalopathy, a serious complication of chronic liver disease. In 2017, Ocera was acquired by Mallinckrodt Pharmaceuticals, which integrated its technology and expertise to strengthen its pipeline of specialty pharmaceutical products.

Ocera Therapeutics Inc - OCRX stocks live chart

Analyze price movements of Ocera Therapeutics Inc online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous OCRX quotes – including the latest bid at 8.8 USD and ask at 9.05 USD – and get all the necessary information for adding Ocera Therapeutics Inc to your investment portfolio.

With R StocksTrader, you can invest in Ocera Therapeutics Inc and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Ocera Therapeutics Inc, and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of OCRX does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Ocera Therapeutics Inc (OCRX).

You can trade Ocera Therapeutics Inc (OCRX) on the R StocksTrader platform.

You can trade online Ocera Therapeutics Inc (OCRX) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts